Trial Profile
Effect of pioglitazone on portal and systemic hemodynamics in patients with advanced cirrhosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2015
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Liver cirrhosis
- Focus Pharmacodynamics
- Acronyms Cirrpio
- 10 Jun 2015 New trial record